| Pancreatic cancer J Kleeff, M Korc, M Apte, C La Vecchia, CD Johnson, AV Biankin, ... Nature reviews Disease primers 2 (1), 1-22, 2016 | 2041 | 2016 |
| Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages S Gillen, T Schuster, C Meyer zum Büschenfelde, H Friess, J Kleeff PLoS medicine 7 (4), e1000267, 2010 | 1848 | 2010 |
| Therapeutic developments in pancreatic cancer: current and future perspectives JP Neoptolemos, J Kleeff, P Michl, E Costello, W Greenhalf, DH Palmer Nature reviews Gastroenterology & hepatology 15 (6), 333-348, 2018 | 1029 | 2018 |
| Most pancreatic cancer resections are R1 resections I Esposito, J Kleeff, F Bergmann, C Reiser, E Herpel, H Friess, ... Annals of surgical oncology 15, 1651-1660, 2008 | 792 | 2008 |
| Systematic review and meta-analysis of the role of defunctioning stoma in low rectal cancer surgery N Hüser, CW Michalski, M Erkan, T Schuster, R Rosenberg, J Kleeff, ... Annals of surgery 248 (1), 52-60, 2008 | 747 | 2008 |
| The role of stroma in pancreatic cancer: diagnostic and therapeutic implications M Erkan, S Hausmann, CW Michalski, AA Fingerle, M Dobritz, J Kleeff, ... Nature reviews Gastroenterology & hepatology 9 (8), 454-467, 2012 | 691 | 2012 |
| Efficacy of stapler versus hand-sewn closure after distal pancreatectomy (DISPACT): a randomised, controlled multicentre trial MK Diener, CM Seiler, I Rossion, J Kleeff, M Glanemann, G Butturini, ... The Lancet 377 (9776), 1514-1522, 2011 | 641 | 2011 |
| Addressing the challenges of pancreatic cancer: future directions for improving outcomes M Hidalgo, S Cascinu, J Kleeff, R Labianca, JM Löhr, J Neoptolemos, ... Pancreatology 15 (1), 8-18, 2015 | 621 | 2015 |
| Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study COVIDSurg Collaborative Anaesthesia 76 (6), 748-758, 2021 | 588* | 2021 |
| Distal pancreatectomy: risk factors for surgical failure in 302 consecutive cases J Kleeff, MK Diener, K Z'graggen, U Hinz, M Wagner, J Bachmann, ... Annals of surgery 245 (4), 573-582, 2007 | 527 | 2007 |
| The activated stroma index is a novel and independent prognostic marker in pancreatic ductal adenocarcinoma M Erkan, CW Michalski, S Rieder, C Reiser–Erkan, I Abiatari, A Kolb, ... Clinical gastroenterology and hepatology 6 (10), 1155-1161, 2008 | 523 | 2008 |
| StellaTUM: current consensus and discussion on pancreatic stellate cell research M Erkan, G Adler, MV Apte, MG Bachem, M Buchholz, S Detlefsen, ... Gut 61 (2), 172-178, 2012 | 486 | 2012 |
| Chronic pancreatitis J Kleeff, DC Whitcomb, T Shimosegawa, I Esposito, MM Lerch, T Gress, ... Nature reviews Disease primers 3 (1), 1-18, 2017 | 482 | 2017 |
| The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer. J Kleeff, T Ishiwata, A Kumbasar, H Friess, MW Büchler, AD Lander, ... The Journal of clinical investigation 102 (9), 1662-1673, 1998 | 459 | 1998 |
| Id-1 and Id-2 are overexpressed in pancreatic cancer and in dysplastic lesions in chronic pancreatitis H Maruyama, J Kleeff, S Wildi, H Friess, MW Büchler, MA Israel, M Korc The American journal of pathology 155 (3), 815-822, 1999 | 439 | 1999 |
| Systematic review and meta-analysis of standard and extended lymphadenectomy in pancreaticoduodenectomy for pancreatic cancer CW Michalski, J Kleeff, MN Wente, MK Diener, MW Büchler, H Friess Journal of British Surgery 94 (3), 265-273, 2007 | 426 | 2007 |
| The TGF-β signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer J Kleeff, T Ishiwata, H Maruyama, H Friess, P Truong, MW Büchler, D Falb, ... Oncogene 18 (39), 5363-5372, 1999 | 404 | 1999 |
| Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma PK Mazur, A Herner, SS Mello, M Wirth, S Hausmann, FJ Sánchez-Rivera, ... Nature medicine 21 (10), 1163-1171, 2015 | 398 | 2015 |
| Pancreatogastrostomy versus pancreatojejunostomy for RECOnstruction after PANCreatoduodenectomy (RECOPANC, DRKS 00000767): perioperative and long-term results of a multicenter … T Keck, UF Wellner, M Bahra, F Klein, O Sick, M Niedergethmann, ... Annals of surgery 263 (3), 440-449, 2016 | 392 | 2016 |
| Periostin creates a tumor-supportive microenvironment in the pancreas by sustaining fibrogenic stellate cell activity M Erkan, J Kleeff, A Gorbachevski, C Reiser, T Mitkus, I Esposito, T Giese, ... Gastroenterology 132 (4), 1447-1464, 2007 | 387 | 2007 |
Mert Erkan MD,PhDProfessor of Surgery, Mehmet Ali Aydınlar Acibadem UniversityVerified email at acibadem.com
